dc.contributor.author | Elliott, Elizabeth | |
dc.contributor.author | Bailey, Olivia | |
dc.contributor.author | Waldron, Fergal M. | |
dc.contributor.author | Hardingham, Giles E. | |
dc.contributor.author | Chandran, Siddharthan | |
dc.contributor.author | Gregory, Jenna M. | |
dc.date.accessioned | 2022-08-03T10:53:01Z | |
dc.date.available | 2022-08-03T10:53:01Z | |
dc.date.issued | 2020-05-25 | |
dc.identifier.citation | Elliott , E , Bailey , O , Waldron , F M , Hardingham , G E , Chandran , S & Gregory , J M 2020 , ' Therapeutic Targeting of Proteostasis in Amyotrophic Lateral Sclerosis — a Systematic Review and Meta-Analysis of Preclinical Research ' , Frontiers in Neuroscience , vol. 14 . https://doi.org/10.3389/fnins.2020.00511 , https://doi.org/10.3389/fnins.2020.00511 | en |
dc.identifier.issn | 1662-4548 | |
dc.identifier.other | PURE: 217891734 | |
dc.identifier.other | PURE UUID: 5fe736d3-680a-4aaa-9819-1d83cac87d67 | |
dc.identifier.other | ORCID: /0000-0003-3337-4079/work/112145055 | |
dc.identifier.other | Scopus: 85086394482 | |
dc.identifier.other | Bibtex: 10.3389/fnins.2020.00511 | |
dc.identifier.uri | https://hdl.handle.net/2164/19000 | |
dc.description | Funding This work was supported by AMS: 210JMG 3102 R45620 and CSO and MNDS: 217ARF R45951. Medical Research Council (MRC UK; MR/L016400/1). | en |
dc.language.iso | eng | |
dc.relation.ispartof | Frontiers in Neuroscience | en |
dc.rights | Copyright © 2020 Elliott, Bailey, Waldron, Hardingham, Chandran and Gregory. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | en |
dc.subject | systematic review | en |
dc.subject | meta-analysis | en |
dc.subject | amyotrophic lateral sclerosis | en |
dc.subject | motor neurone disease | en |
dc.subject | proteostasis, preclinical | en |
dc.subject | therapeutic | en |
dc.subject | survival | en |
dc.subject | RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry | en |
dc.subject | Medical Research Council (MRC) | en |
dc.subject | MR/L016400/1 | en |
dc.subject.lcc | RC0321 | en |
dc.title | Therapeutic Targeting of Proteostasis in Amyotrophic Lateral Sclerosis — a Systematic Review and Meta-Analysis of Preclinical Research | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.3389/fnins.2020.00511 | |
dc.identifier.url | http://dx.doi.org/10.3389/fnins.2020.00511 | en |
dc.identifier.url | https://www.frontiersin.org/articles/10.3389/fnins.2020.00511 | en |
dc.identifier.vol | 14 | en |